United States · FDA National Drug Code directory
FUROSEMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1574_100cb889-1a7e-6252-e063-6394a90a9221
- Product NDC
- 51662-1574
- Form
- INJECTION, SOLUTION
- Composition / generic term
- FUROSEMIDE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210628
- Source listing expiry
- 20261231
Source-listed ingredients
- FUROSEMIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 mL in 1 VIAL (51662-1574-1) · 51662-1574-1
- 25 POUCH in 1 CASE (51662-1574-3) / 1 VIAL in 1 POUCH (51662-1574-2) / 4 mL in 1 VIAL · 51662-1574-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →